Orser Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,796
| Closed | -$251K | – | 83 |
|
|
2022
Q1 | $251K | Buy |
2,796
+480
| +21% | +$43.1K | 0.15% | 77 |
|
|
2021
Q4 | $259K | Sell |
2,316
-980
| -30% | -$110K | 0.13% | 84 |
|
|
2021
Q3 | $414K | Sell |
3,296
-7,867
| -70% | -$988K | 0.23% | 68 |
|
|
2021
Q2 | $1.51M | Buy |
11,163
+3,181
| +40% | +$431K | 0.78% | 48 |
|
|
2021
Q1 | $1.08M | Buy |
7,982
+3,239
| +68% | +$439K | 0.7% | 47 |
|
|
2020
Q4 | $668K | Buy |
4,743
+1,820
| +62% | +$256K | 0.42% | 60 |
|
|
2020
Q3 | $326K | Buy |
+2,923
| New | +$326K | 0.26% | 61 |
|
|
2020
Q2 | – | Sell |
-2,643
| Closed | -$205K | – | 65 |
|
|
2020
Q1 | $205K | Sell |
2,643
-9,591
| -78% | -$744K | 0.29% | 55 |
|
|
2019
Q4 | $1.16M | Buy |
12,234
+8,580
| +235% | +$813K | 1.12% | 35 |
|
|
2019
Q3 | $287K | Hold |
3,654
| – | – | 0.34% | 55 |
|
|
2019
Q2 | $336K | Sell |
3,654
-263
| -7% | -$24.2K | 0.35% | 53 |
|
|
2019
Q1 | $355K | Sell |
3,917
-770
| -16% | -$69.8K | 0.39% | 52 |
|
|
2018
Q4 | $411K | Hold |
4,687
| – | – | 0.47% | 51 |
|
|
2018
Q3 | $411K | Buy |
4,687
+720
| +18% | +$63.1K | 0.39% | 61 |
|
|
2018
Q2 | $399K | Sell |
3,967
-1,635
| -29% | -$164K | 0.35% | 71 |
|
|
2018
Q1 | $496K | Sell |
5,602
-12,085
| -68% | -$1.07M | 0.46% | 64 |
|
|
2017
Q4 | $1.56M | Buy |
+17,687
| New | +$1.56M | 1.39% | 33 |
|